Ingrid Potyka

1.8k total citations
11 papers, 137 citations indexed

About

Ingrid Potyka is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ingrid Potyka has authored 11 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Cancer Research and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ingrid Potyka's work include Breast Cancer Treatment Studies (5 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Prostate Cancer Treatment and Research (3 papers). Ingrid Potyka is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Prostate Cancer Treatment and Research (3 papers). Ingrid Potyka collaborates with scholars based in United Kingdom, Germany and Australia. Ingrid Potyka's co-authors include Norman Williams, Jayant S. Vaidya, Frederik Wenz, Max Bulsara, Jeffrey Tobias, Chris Brew‐Graves, Michael Baum, Christobel Saunders, Stephen Morris and Julian M. Singer and has published in prestigious journals such as The Journal of Urology, Radiotherapy and Oncology and BMJ Open.

In The Last Decade

Ingrid Potyka

11 papers receiving 131 citations

Peers

Ingrid Potyka
Hrisheekesh J Vaidya United Kingdom
Iris E. van Dam Netherlands
Adam Critchley United Kingdom
P Rovea Italy
James Flannery United States
Kathryn Masi United States
Hrisheekesh J Vaidya United Kingdom
Ingrid Potyka
Citations per year, relative to Ingrid Potyka Ingrid Potyka (= 1×) peers Hrisheekesh J Vaidya

Countries citing papers authored by Ingrid Potyka

Since Specialization
Citations

This map shows the geographic impact of Ingrid Potyka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Potyka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Potyka more than expected).

Fields of papers citing papers by Ingrid Potyka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Potyka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Potyka. The network helps show where Ingrid Potyka may publish in the future.

Co-authorship network of co-authors of Ingrid Potyka

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Potyka. A scholar is included among the top collaborators of Ingrid Potyka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Potyka. Ingrid Potyka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Orczyk, Clément, Dean C. Barratt, Chris Brew‐Graves, et al.. (2020). Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer. The Journal of Urology. 205(4). 1090–1099. 17 indexed citations
2.
Martín, Daniel, Chris Brew‐Graves, Neil McCartan, et al.. (2019). Protocol for a feasibility randomised controlled trial of targeted oxygen therapy in mechanically ventilated critically ill patients. BMJ Open. 9(1). e021674–e021674. 5 indexed citations
4.
Orczyk, Clément, Chris Brew‐Graves, Norman Williams, et al.. (2018). MP30-05 PROSTATE RADIOFREQUENCY ABLATION FOCAL TREATMENT (PRORAFT): RESULTS OF A PROSPECTIVE DEVELOPMENT STUDY FOR LOCALISED PROSTATE CANCER. The Journal of Urology. 199(4S). 2 indexed citations
5.
Donaldson, Ian, Dean C. Barratt, Yipeng Hu, et al.. (2017). MP33-20 THE SMARTTARGET BIOPSY TRIAL: A PROSPECTIVE PAIRED BLINDED TRIAL WITH RANDOMISATION TO COMPARE VISUAL-ESTIMATION AND IMAGE-FUSION TARGETED PROSTATE BIOPSIES. The Journal of Urology. 197(4S). 5 indexed citations
6.
Bass, Edward, Alex Freeman, Chris Brew‐Graves, et al.. (2017). Intra-prostatic injection of PRX302 to focally ablate clinically significant prostate cancer: An open label, phase 2a study. European Urology Supplements. 16(3). e1308–e1309. 2 indexed citations
7.
Coombs, Nathan, Julian M. Singer, Max Bulsara, et al.. (2016). Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT. BMJ Open. 6(5). e010703–e010703. 60 indexed citations
9.
Vaidya, Jayant S., Mahesh Bulsara, Frederik Wenz, et al.. (2015). OC-0472: Whole breast radiotherapy does not affect growth of cancer foci in other quadrants: results from the TARGIT Atrial. Radiotherapy and Oncology. 115. S232–S233. 1 indexed citations
10.
Vaidya, Jayant S., Max Bulsara, Samuele Massarut, et al.. (2015). Whole breast radiotherapy does not affect growth of cancer foci in other quadrants: results from the TARGIT A trial. UCL Discovery (University College London). 1 indexed citations
11.
Potyka, Ingrid, et al.. (2001). Prophylactic radiotherapy following surgery for early breast cancer - is the benefit mainly to patients with involved margins? Results from a Cancer Research Campaign Trial. UCL Discovery (University College London). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026